FRANKLIN LAKES, N.J.,
July 27, 2020 /PRNewswire/
-- The Board of Directors of BD (Becton, Dickinson and
Company) (NYSE: BDX) has declared a quarterly dividend of
$0.79 per common share, payable on
September 30, 2020 to holders of
record on September 9, 2020.
The indicated annual dividend rate is $3.16 per share. In addition, the Board of
Directors has declared a quarterly dividend of $15.8333334 per share on the 6.00% mandatory
convertible preferred stock, Series B, payable on September 1, 2020 to holders of record on
August 15, 2020. This
represents $0.79166667 per depositary
share (NYSE: BDXB).
About BD
BD is one of the largest global medical
technology companies in the world and is advancing the world of
health by improving medical discovery, diagnostics and the delivery
of care. The company supports the heroes on the frontlines of
healthcare by developing innovative technology, services and
solutions that help advance both clinical therapy for patients and
clinical process for healthcare providers. BD and its 65,000
employees have a passion and commitment to help enhance the safety
and efficiency of clinicians' care delivery process, enable
laboratory scientists to accurately detect disease and advance
researchers' capabilities to develop the next generation of
diagnostics and therapeutics. BD has a presence in virtually every
country and partners with organizations around the world to address
some of the most challenging global health issues. By working in
close collaboration with customers, BD can help enhance outcomes,
lower costs, increase efficiencies, improve safety and expand
access to healthcare. For more information on BD, please visit
bd.com.
Contact:
Kristen Cardillo, Corporate
Communications – 201-847-5657
Monique N. Dolecki, Investor
Relations – 201-847-5378
View original
content:http://www.prnewswire.com/news-releases/bd-board-declares-dividends-301100407.html
SOURCE BD (Becton, Dickinson and Company)